IBM Watson Health last year formally jumped into predictive analytics, and has been on a tear ever since, doing deals and partnering with health care providers and commercial enterprises. For years, IBM had a traditional computer infrastructure business in health care. But executives figured out that the combination of its supercomputing Watson technology with the explosion of data would create opportunities in many areas, says Kathy McGroddy Goetz, vice president of partners and solutions for IBM Watson. “We had this idea and decided the timing was right.” IBM Watson launched at the annual HIMSS conference in 2015. In addition to partnerships with Apple Computer, Johnson & Johnson, Epic, CVS and Medtronic, among others, the company has clinical partnerships with providers and has entered deals to buy several companies, a selection of which are below.
IBM Clinical Partnerships in Cancer
• Memorial Sloan Kettering Cancer Center is working with IBM to train and co-develop a Watson-powered app to scale the expertise of oncologists, serve as a decision support tool for oncologists worldwide and develop personalized treatment options for cancer patients.
• The Mayo Clinic is using Watson to match patients more quickly with appropriate clinical trials.
• IBM researchers are working with Cleveland Clinic to use IBM Watson technology as a collaborative learning tool in the medical field and to cull new insights from electronic health records.
• IBM is working with the University of Texas MD Anderson Cancer Center to develop a Watson-powered technology that helps physicians and researchers expand treatment options, match patients with clinical trials and accelerate novel discoveries into the fight against cancer, starting with leukemia.
• Researchers at the New York Genome Center are testing a Watson prototype designed specifically for genomic research as a tool to help oncologists deliver more-personalized care to cancer patients.
Explorys: Identifies patterns in diseases, treatments and outcomes, integrating more than 315 billion clinical, financial and operational data elements.
Phytel: A provider of cloud-based population health management software that works with health care providers’ current electronic health record technologies to reduce hospital readmissions and to automate and improve patient outreach and engagement.
Merge Healthcare: Watson will gain the ability to “see” by bringing together its advanced image analytics and cognitive capabilities with data and images from Merge’s medical imaging management platform.
Truven Health Analytics: Upon completion of a February agreement, IBM’s health cloud will house a large and diverse collection of health-related data. IBM plans to integrate Truven’s extensive cloud-based data set spanning hundreds of different types of cost, claims, quality and outcomes information with its existing data sets.
Source: IBM Watson Health, 2016